While testing the effect of the (β15-66)(2) fragment, which mimics a pair of
fibrin βN-domains, on the morphology of endothelial cells, we found that this fragment induces redistribution of
vascular endothelial-cadherin in a process that is inhibited by the receptor-associated
protein (RAP). Based on this finding, we hypothesized that
fibrin may interact with members of RAP-dependent
low-density lipoprotein (
LDL) receptor family. To test this hypothesis, we examined the interaction of (β15-66)(2),
fibrin, and several
fibrin-derived fragments with 2 members of this family by ELISA and surface plasmon resonance. The experiments showed that very
LDL (
VLDL) receptor (VLDLR) interacts with high affinity with
fibrin through its βN-domains, and this interaction is inhibited by RAP and (β15-66)(2). Furthermore, RAP inhibited transendothelial migration of neutrophils induced by
fibrin-derived
NDSK-II fragment containing βN-domains, suggesting the involvement of VLDLR in
fibrin-dependent leukocyte transmigration. Our experiments with VLDLR-deficient mice confirmed this suggestion by showing that, in contrast to wild-type mice,
fibrin-dependent leukocyte transmigration does not occur in such mice. Altogether, the present study identified VLDLR as a novel endothelial cell receptor for
fibrin that promotes
fibrin-dependent leukocyte transmigration and thereby
inflammation. Establishing the molecular mechanism underlying this interaction may result in the development of novel inhibitors of
fibrin-dependent
inflammation.